Zobrazeno 1 - 10
of 65
pro vyhledávání: '"Shia T Kent"'
Autor:
Adolfo Correa, Annie Green Howard, Kari E North, Jerome I Rotter, Stephen S Rich, Ulrike Peters, Zhe Wang, Michael Y Tsai, Penny Gordon-Larsen, Christie Ballantyne, Shia T Kent, Ruth J F Loos, Christy L Avery, Xiuqing Guo, Jie Yao, Yao Hu, Mariaelisa Graff, Paul S de Vries, Keri L Monda, Moa P Lee, Sofia F Dimos, Laura M Raffield, Anna F Ballou, Carolina G Downie, Christopher H Arehart, Zhaohui Du, Christopher R Gignoux, Jeffrey Haessler, Helina Kassahun, J Antonio G Lopez, Michael H Preuss, Shannon L Rhodes, Rina Yarosh, Charles L Kooperberg
Publikováno v:
Open Heart, Vol 10, Iss 2 (2023)
Introduction The independent and causal cardiovascular disease risk factor lipoprotein(a) (Lp(a)) is elevated in >1.5 billion individuals worldwide, but studies have prioritised European populations.Methods Here, we examined how ancestrally diverse s
Externí odkaz:
https://doaj.org/article/1a269fc98b7043cc85c2bdef81e77451
Ambulatory Blood Pressure Monitoring in Individuals with HIV: A Systematic Review and Meta-Analysis.
Autor:
Shia T Kent, Samantha G Bromfield, Greer A Burkholder, Louise Falzon, Suzanne Oparil, Edgar T Overton, Michael J Mugavero, Joseph E Schwartz, Daichi Shimbo, Paul Muntner
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0148920 (2016)
IntroductionAbnormal diurnal blood pressure (BP) rhythms may contribute to the high cardiovascular disease risk in HIV-positive (HIV+) individuals. To synthesize the current literature on ambulatory BP monitoring (ABPM) in HIV+ individuals, a systema
Externí odkaz:
https://doaj.org/article/fac9e77114694c15ad497e6eb02410c5
Autor:
Ngan T Tran, Stella eAslibekyan, Hemant K Tiwari, Degui eZhi, Yun Ju Sung, DC eRao, Steven C. Hunt, Ulrich eBroeckel, Donna K Arnett, Suzanne E Judd, Paul eMuntner, Shia T Kent, Ryan eIrvin
Publikováno v:
Frontiers in Genetics, Vol 6 (2015)
Proprotein convertase subtilisin/kexin type 9 (encoded by PCSK9) plays a well-known role in the regulation of low-density lipoprotein (LDL) receptors, and an inhibitor of this enzyme is a promising new therapeutic for hyperlipidemia. Recently, animal
Externí odkaz:
https://doaj.org/article/76c90c718c4e4af9a40cfe79837c2dcc
Autor:
Matthew Shane Loop, Shia T Kent, Mohammad Z Al-Hamdan, William L Crosson, Sue M Estes, Maurice G Estes, Dale A Quattrochi, Sarah N Hemmings, Virginia G Wadley, Leslie A McClure
Publikováno v:
PLoS ONE, Vol 10, Iss 4, p e0125137 (2015)
Externí odkaz:
https://doaj.org/article/5b0594d1ebdd4f2abb13275717b4dcd2
Autor:
Shia T Kent, Daichi Shimbo, Lei Huang, Keith M Diaz, Meredith L Kilgore, Suzanne Oparil, Paul Muntner
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e105888 (2014)
BACKGROUND:After the 2003 publication of the Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) guidelines, there was a 5-10% increase in patients initiating antihypertens
Externí odkaz:
https://doaj.org/article/4c8014b9c4ea4a2c81bb38bd6094d36e
Autor:
Matthew Shane Loop, Shia T Kent, Mohammad Z Al-Hamdan, William L Crosson, Sue M Estes, Maurice G Estes, Dale A Quattrochi, Sarah N Hemmings, Virginia G Wadley, Leslie A McClure
Publikováno v:
PLoS ONE, Vol 8, Iss 9, p e75001 (2013)
Studies of the effect of air pollution on cognitive health are often limited to populations living near cities that have air monitoring stations. Little is known about whether the estimates from such studies can be generalized to the U.S. population,
Externí odkaz:
https://doaj.org/article/b61262ce58ec474c91bbde90149c0b44
Autor:
Lisandro D. Colantonio, Vera Bittner, Monika M. Safford, Santica Marcovina, Todd M. Brown, Elizabeth A. Jackson, Mei Li, J. Antonio G. López, Keri L. Monda, Timothy B. Plante, Shia T. Kent, Paul Muntner, Robert S. Rosenson
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 11 (2022)
Background It is unclear whether lipoprotein(a) is associated with coronary heart disease (CHD) and ischemic stroke events in White and Black adults with atherosclerotic cardiovascular disease (ASCVD). Methods and Results We conducted a case‐cohort
Externí odkaz:
https://doaj.org/article/dee9523a83154151a2146b33a52a1bcd
Autor:
Parag H. Joshi, Santica Marcovina, Kate Orroth, J. Antonio G. López, Shia T. Kent, Robert Kaplan, Katrina Swett, Daniela Sotres-Alvarez, Bharat Thyagarajan, Leandro Slipczuk, Tamar Sofer, Martha L. Daviglus, Gregory A. Talavera, Neil Schneiderman, Carlos J. Rodriguez
Publikováno v:
JAMA Cardiology.
ImportanceLipoprotein(a) (Lp[a]) is a genetically determined risk-enhancing factor for atherosclerotic cardiovascular disease (ASCVD). The Lp(a) distribution among the diverse Hispanic or Latino community residing in the US has not been previously de
Autor:
Michelle D. Kelsey, Hillary Mulder, Karen Chiswell, Zachary M. Lampron, Ester Nilles, Jacquelyn P. Kulinski, Parag H. Joshi, W. Schuyler Jones, Alanna M. Chamberlain, Thorsten M. Leucker, Wenke Hwang, M. Wesley Milks, Anuradha Paranjape, Jihad S. Obeid, MacRae F. Linton, Shia T. Kent, Eric D. Peterson, Emily C. O'Brien, Neha J. Pagidipati
Publikováno v:
Am J Prev Cardiol
OBJECTIVE: Elevated lipoprotein(a) [Lp(a)] is associated with atherosclerotic cardiovascular disease, yet little is known about Lp(a) testing patterns in real-world practice. The objective of this analysis was to determine how Lp(a) testing is used i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a51a926cc042231cc20c06b6d2cc01d6
https://europepmc.org/articles/PMC10070377/
https://europepmc.org/articles/PMC10070377/
Publikováno v:
Administration and Policy in Mental Health and Mental Health Services Research. 49:658-669